Literature DB >> 31386928

Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism.

Yanping Sun1, Xiaoqian Lv2, Pingtian Ding3, Long Wang4, Yongjun Sun5, Shuo Li6, Huimin Zhang6, Zibin Gao7.   

Abstract

Adenovirus (Ad) is a promising viral carrier in gene therapy because of its unique attribution. However, clinical applications of Ad vectors are currently restricted by their immunogenicity and broad native tropism. To address these obstacles, a variety of nonimmunogenic polymers are utilized to modify Ad vectors chemically or physically. In this review, we systemically discuss the functions of polymers in Ad-mediated gene delivery from two aspects: evading the host immune responses to Ads and redirecting Ad tropism. With polyethylene glycol (PEG) first in order, a variety of polymers have been developed to shield the surface of Ad vectors and well accomplished to evade the host immune response, block CAR-dependant cellular uptake, and reduce accumulation in the liver. In addition, shielding Ad vectors with targeted polymers (including targeting ligand-conjugated polymers and bio-responsive polymers) can also efficiently retarget Ad vectors to tumor tissues and reduce their distribution in nontargeted tissues. With its potential to evade the immune response and retarget Ad vectors, modification with polymers has been generally regarded as a promising strategy to facilitate the clinical applications of Ad vectors for virotherapy. STATEMENT OF SIGNIFICANCE: There is no doubt that Adenovirus (Ads) are attractive vectors for gene therapy, with high sophistication and effectiveness in overcoming both extra- and intracellular barriers, which cannot be exceeded by any other nonviral gene vectors. Unfortunately, their clinical applications are still restricted by some critical hurdles, including immunogenicity and native broad tropism. Therefore, a variety of elegant strategies have been developed from various angles to address these hurdles. Among these various strategies, coating Ads with nonimmunogenic polymers has attracted much attention. In this review, we systemically discuss the functions of polymers in Ad-mediated gene delivery from two aspects: evading the host immune responses to Ads and redirecting Ad tropism. In addition, the key factors in Ad modification with polymers have been highlighted and summarized to provide guiding theory for the design of more effective and safer polymer-Ad hybrid gene vectors.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenovirus; Gene delivery; Immune response; Polymers; Tropism

Year:  2019        PMID: 31386928     DOI: 10.1016/j.actbio.2019.06.059

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  11 in total

Review 1.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

Review 2.  High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Authors:  Ana Ricobaraza; Manuela Gonzalez-Aparicio; Lucia Mora-Jimenez; Sara Lumbreras; Ruben Hernandez-Alcoceba
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

Review 3.  Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease.

Authors:  Isabel N Schellinger; Angelika R Dannert; Karin Mattern; Uwe Raaz; Philip S Tsao
Journal:  Front Cardiovasc Med       Date:  2021-04-15

4.  Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.

Authors:  Mónika Z Ballmann; Svjetlana Raus; Ruben Engelhart; Győző L Kaján; Abdelaziz Beqqali; Patrick W F Hadoke; Chantal van der Zalm; Tibor Papp; Lijo John; Selina Khan; Satish Boedhoe; Katarina Danskog; Lars Frängsmyr; Jerome Custers; Wilfried A M Bakker; Hilde M van der Schaar; Niklas Arnberg; Angelique A C Lemckert; Menzo Havenga; Andrew H Baker
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

5.  Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases.

Authors:  Nuseibah Al Qtaish; Idoia Gallego; Alejandro J Paredes; Ilia Villate-Beitia; Cristina Soto-Sánchez; Gema Martínez-Navarrete; Myriam Sainz-Ramos; Tania B Lopez-Mendez; Eduardo Fernández; Gustavo Puras; José Luis Pedraz
Journal:  ACS Appl Mater Interfaces       Date:  2022-03-15       Impact factor: 9.229

Review 6.  Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses.

Authors:  Thavasyappan Thambi; JinWoo Hong; A-Rum Yoon; Chae-Ok Yun
Journal:  Cancer Gene Ther       Date:  2022-04-20       Impact factor: 5.854

7.  Carboxymethyl chitosan prolongs adenovirus-mediated expression of IL-10 and ameliorates hepatic fibrosis in a mouse model.

Authors:  Yannian Gou; Yaguang Weng; Qian Chen; Jinghong Wu; Hao Wang; Jiamin Zhong; Yang Bi; Daigui Cao; Piao Zhao; Xiangyu Dong; Meichun Guo; William Wagstaff; Bryce Hendren-Santiago; Connie Chen; Andrew Youssef; Rex C Haydon; Hue H Luu; Russell R Reid; Le Shen; Tong-Chuan He; Jiaming Fan
Journal:  Bioeng Transl Med       Date:  2022-03-10

Review 8.  Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.

Authors:  Rebeca Gonzalez-Pastor; Peter S Goedegebuure; David T Curiel
Journal:  Cancer Gene Ther       Date:  2020-09-19       Impact factor: 5.987

Review 9.  Novel vectors and approaches for gene therapy in liver diseases.

Authors:  Sheila Maestro; Nicholas D Weber; Nerea Zabaleta; Rafael Aldabe; Gloria Gonzalez-Aseguinolaza
Journal:  JHEP Rep       Date:  2021-04-30

10.  A pH- and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery.

Authors:  Thavasyappan Thambi; Jeongmin Lee; A-Rum Yoon; Dayananda Kasala; Chae-Ok Yun
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.